Original research article Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study

This 1-year randomized study was carried out at family-planning clinics of two university hospitals to compare the safety and acceptability of a levonorgestrel-releasing intrauterine system (LNG IUS) and oral contraceptives (OCs) in young nulliparous women. The study population consisted of 200 women aged 18 –25 years seeking contraception. Ninety-four women entered the LNG IUS group and 99 entered the OC group. Continuation rates, reasons leading to discontinuation, adverse events, menstrual questionnaires, subjective well-being and sexual behavior were evaluated. Nineteen women (20%) in the LNG IUS group discontinued the study during the 1-year observation period, and 27 discontinued (27%) in the OC group. The most common reason (31%) for discontinuation in the IUS group was pain. In the OC group, hormonal side effects were the predominant medical reason for study termination. The safety and acceptability of the LNG IUS for contraception was observed to be as good as with OCs, with a high continuation rate. © 2004 Elsevier Inc. All rights reserved.

[1]  Douglas J. Taylor,et al.  Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women , 2002 .

[2]  K. Schulz,et al.  Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. , 1999, Contraception.

[3]  I. den Tonkelaar,et al.  Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. , 1999, Contraception.

[4]  M. Rosenberg,et al.  Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. , 1998, American journal of obstetrics and gynecology.

[5]  J. Peipert,et al.  Oral contraception and the recognition of endometritis. , 1997, American journal of obstetrics and gynecology.

[6]  J. Henry-suchet,et al.  Chlamydia trachomatis screening in family planning centers: a review of cost/benefit evaluations in different countries. , 1996, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[7]  J. Suvisaari,et al.  Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. , 1996, Contraception.

[8]  K. Anderson.  Intrauterine release of levonorgestrel: A contraceptive and therapeutical system , 1995 .

[9]  V. Odlind,et al.  Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. , 1994, Contraception.

[10]  I. Sivin,et al.  Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). , 1994, Fertility and sterility.

[11]  I. Milsom,et al.  The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. , 1993, Contraception.

[12]  L. Bahamondes,et al.  Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women? , 1993, Contraception.

[13]  T. Farley,et al.  Intrauterine devices and pelvic inflammatory disease: an international perspective , 1992, The Lancet.

[14]  I. Milsom,et al.  A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. , 1991, American journal of obstetrics and gynecology.

[15]  J. Toivonen,et al.  Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years' Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine Devices , 1991, Obstetrics and gynecology.

[16]  W. Phipps,et al.  Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease. , 1991, Contraception.

[17]  D. Mishell,et al.  Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. , 1990, Contraception.

[18]  T. Farley,et al.  The analysis of menstrual bleeding patterns: a review. , 1988, Contraception.

[19]  N. Nielsen,et al.  Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. , 1987, Contraception.

[20]  G. Rybo,et al.  Treatment of menorrhagia with intrauterine release of progesterone , 1983 .

[21]  N. Nielsen,et al.  Nulliparous women, IUD and pelvic infection. , 1979, Annals of clinical research.